Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2'-deoxy-2'-beta-fluoro-4'-azidocytidine
2. 4'-azido-2'-deoxy-2'-fluorocytidine
3. 4-amino-1-((2r,3r,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-5-((imino-l,5-azanylidene)amino)tetrahydrofuran-2-yl)pyrimidin-2-one
4. 4-amino-1-((2r,3s,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-5-((imino-l,5-azanylidene)amino)tetrahydrofuran-2-yl)pyrimidin-2-one
5. Ro-0622
1. Ro-0622
2. 1011529-10-4
3. 4-amino-1-((2r,3s,4r,5r)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1h)-one
4. 4-amino-1-[(2r,3s,4r,5r)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
5. Chembl519846
6. Fncro-0622
7. 4'-c-azido-2'-deoxy-2'-fluoro-beta-d-arabinocytidine
8. Schembl15866623
9. Dtxsid901027757
10. Glxc-25994
11. Hy-19314
12. Cs-0015081
13. A848947
14. 2(1h)-pyrimidinone, 4-amino-1-(4-c-azido-2-deoxy-2-fluoro-b-d-arabinofuranosyl)-
15. 4-amino-1-[(2r,3s,4r,5r)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
| Molecular Weight | 286.22 g/mol |
|---|---|
| Molecular Formula | C9H11FN6O4 |
| XLogP3 | -0.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 286.08258102 g/mol |
| Monoisotopic Mass | 286.08258102 g/mol |
| Topological Polar Surface Area | 123 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 533 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 1 |
| Covalently Bonded Unit Count | 1 |
Azvudine is a nucleoside reverse transcriptase inhibitor that acts against HIV, HBV, and HCV. Some studies also show that it is able to modulate the expression of proteins like P-glycoprotein (P-gp), MRP2, and BCRP; in one instance, it was also able to increase the activity of P-gp. In 2020, the compound was tested in numerous clinical trials for the treatment of mild and common COVID-19.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
14
PharmaCompass offers a list of Azvudine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Azvudine manufacturer or Azvudine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Azvudine manufacturer or Azvudine supplier.
PharmaCompass also assists you with knowing the Azvudine API Price utilized in the formulation of products. Azvudine API Price is not always fixed or binding as the Azvudine Price is obtained through a variety of data sources. The Azvudine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Azvudine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azvudine, including repackagers and relabelers. The FDA regulates Azvudine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azvudine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Azvudine supplier is an individual or a company that provides Azvudine active pharmaceutical ingredient (API) or Azvudine finished formulations upon request. The Azvudine suppliers may include Azvudine API manufacturers, exporters, distributors and traders.
Azvudine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azvudine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azvudine GMP manufacturer or Azvudine GMP API supplier for your needs.
A Azvudine CoA (Certificate of Analysis) is a formal document that attests to Azvudine's compliance with Azvudine specifications and serves as a tool for batch-level quality control.
Azvudine CoA mostly includes findings from lab analyses of a specific batch. For each Azvudine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azvudine may be tested according to a variety of international standards, such as European Pharmacopoeia (Azvudine EP), Azvudine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azvudine USP).
